217 related articles for article (PubMed ID: 24763373)
1. Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom.
Long EF; Mandalia R; Mandalia S; Alistar SS; Beck EJ; Brandeau ML
PLoS One; 2014; 9(4):e95735. PubMed ID: 24763373
[TBL] [Abstract][Full Text] [Related]
2. Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.
Long EF; Stavert RR
J Gen Intern Med; 2013 Oct; 28(10):1294-301. PubMed ID: 23588668
[TBL] [Abstract][Full Text] [Related]
3. HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis.
Long EF
PLoS One; 2011; 6(11):e27625. PubMed ID: 22110698
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USA.
Juusola JL; Brandeau ML; Long EF; Owens DK; Bendavid E
AIDS; 2011 Sep; 25(14):1779-87. PubMed ID: 21716076
[TBL] [Abstract][Full Text] [Related]
5. Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK.
Brogan AJ; Talbird SE; Davis AE; Wild L; Flanagan D
HIV Med; 2019 Nov; 20(10):668-680. PubMed ID: 31392813
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.
Long EF; Brandeau ML; Owens DK
Ann Intern Med; 2010 Dec; 153(12):778-89. PubMed ID: 21173412
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men.
Juusola JL; Brandeau ML; Owens DK; Bendavid E
Ann Intern Med; 2012 Apr; 156(8):541-50. PubMed ID: 22508731
[TBL] [Abstract][Full Text] [Related]
8. The Cost-Effectiveness of Human Immunodeficiency Virus Testing and Treatment Engagement Initiatives in British Columbia, Canada: 2011-2013.
Nosyk B; Min JE; Krebs E; Zang X; Compton M; Gustafson R; Barrios R; Montaner JSG;
Clin Infect Dis; 2018 Feb; 66(5):765-777. PubMed ID: 29028964
[TBL] [Abstract][Full Text] [Related]
9. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
Alistar SS; Owens DK; Brandeau ML
PLoS Med; 2011 Mar; 8(3):e1000423. PubMed ID: 21390264
[TBL] [Abstract][Full Text] [Related]
11. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.
Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP
Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002
[TBL] [Abstract][Full Text] [Related]
12. Rising population cost for treating people living with HIV in the UK, 1997-2013.
Mandalia S; Mandalia R; Lo G; Chadborn T; Sharott P; Youle M; Anderson J; Baily G; Brettle R; Fisher M; Gompels M; Kinghorn G; Johnson M; McCarron B; Pozniak A; Tang A; Walsh J; White D; Williams I; Gazzard B; Beck EJ;
PLoS One; 2010 Dec; 5(12):e15677. PubMed ID: 21209893
[TBL] [Abstract][Full Text] [Related]
13. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis.
Baggaley RF; Irvine MA; Leber W; Cambiano V; Figueroa J; McMullen H; Anderson J; Santos AC; Terris-Prestholt F; Miners A; Hollingsworth TD; Griffiths CJ
Lancet HIV; 2017 Oct; 4(10):e465-e474. PubMed ID: 28768604
[TBL] [Abstract][Full Text] [Related]
15. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N
Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility of HIV Testing Programs Among Men Who Have Sex with Men in the United States.
Zulliger R; Maulsby C; Solomon L; Baytop C; Orr A; Nasrullah M; Shouse L; DiNenno E; Holtgrave D
AIDS Behav; 2017 Mar; 21(3):619-625. PubMed ID: 27624729
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States.
Boettiger DC; Newall AT; Phillips A; Bendavid E; Law MG; Ryom L; Reiss P; Mocroft A; Bonnet F; Weber R; El-Sadr W; d'Arminio Monforte A; de Wit S; Pradier C; Hatleberg CI; Lundgren J; Sabin C; Kahn JG; Kazi DS
J Int AIDS Soc; 2021 Mar; 24(3):e25690. PubMed ID: 33749164
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial.
Schackman BR; Metsch LR; Colfax GN; Leff JA; Wong A; Scott CA; Feaster DJ; Gooden L; Matheson T; Haynes LF; Paltiel AD; Walensky RP
Drug Alcohol Depend; 2013 Feb; 128(1-2):90-7. PubMed ID: 22971593
[TBL] [Abstract][Full Text] [Related]
19. Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis.
Scott RK; Crochet S; Huang CC
Infect Dis Obstet Gynecol; 2018; 2018():6024698. PubMed ID: 29731602
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.
Zang X; Tang H; Min JE; Gu D; Montaner JS; Wu Z; Nosyk B
PLoS One; 2016; 11(11):e0167308. PubMed ID: 27893864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
